Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Swathi Ramakrishnan

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cell Death & Disease|December 16, 2017
Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancerSwathi Ramakrishnan, Qiang Hu, Nithya Krishnan, et al.
Molecular Cancer Therapeutics|December 19, 2014
Sunitinib dose escalation overcomes transient resistance in clear cell renal cell carcinoma and is associated with epigenetic modificationsRemi Adelaiye, Eric Ciamporcero, Kiersten Marie Miles, et al.
Oncotarget|November 9, 2016
Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenograftsLei Wei, Sreenivasulu Chintala, Eric Ciamporcero, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyAmar Gajjar, Anita Mahajan, Tejus Bale, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026Apar Kishor P Ganti, Billy W Loo, Shahed Badiyan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024Joyce Liu, Andrew Berchuck, Floor J Backes, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 17, 2025
NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2025Douglas E Wood, Ella A Kazerooni, Denise R Aberle, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cell Death & Disease|December 16, 2017
Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancerSwathi Ramakrishnan, Qiang Hu, Nithya Krishnan, et al.
Molecular Cancer Therapeutics|December 19, 2014
Sunitinib dose escalation overcomes transient resistance in clear cell renal cell carcinoma and is associated with epigenetic modificationsRemi Adelaiye, Eric Ciamporcero, Kiersten Marie Miles, et al.
Oncotarget|November 9, 2016
Genomic profiling is predictive of response to cisplatin treatment but not to PI3K inhibition in bladder cancer patient-derived xenograftsLei Wei, Sreenivasulu Chintala, Eric Ciamporcero, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyAmar Gajjar, Anita Mahajan, Tejus Bale, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
NCCN Guidelines® Insights: Small Cell Lung Cancer, Version 2.2026Apar Kishor P Ganti, Billy W Loo, Shahed Badiyan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 16, 2024
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024Joyce Liu, Andrew Berchuck, Floor J Backes, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 17, 2025
NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2025Douglas E Wood, Ella A Kazerooni, Denise R Aberle, et al.
Pageof 3